OTUD7B and esophageal squamous cell carcinoma: Additionally, clinical studies are needed to assess the expression levels of METTL14, OTUD7B, and HIF-1α in patient populations at risk for advanced ESCC, which could lead to the identification of biomarkers for early detection and risk stratification.